Chronic Kidney Disease Clinical Trial
Official title:
Targeting Social Determinants to Improve Chronic Kidney Disease Care
Verified date | July 2014 |
Source | Vanderbilt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The primary research goals of this application are to characterize social factors including
health literacy and numeracy skills of CKD patients and examine associations with knowledge,
self-efficacy, self-care behaviors, and clinical outcomes, and to examine the impact of an
efficient interactive educational intervention to facilitate patient-provider communication.
The investigators will accomplish these goals by executing a cluster-randomized controlled
trial and performing detailed analysis of baseline measures. The specific aims of this study
are:
Specific Aim 1: Determine the association of social factors with patient kidney knowledge,
self-efficacy, participation in self-care behaviors, and clinical outcomes in moderate to
advanced CKD.
Hypothesis: In patients with CKD, low health literacy and numeracy is common and associated
with older age, non-white race, fewer years of education, lower socioeconomic (income)
status, less kidney knowledge, lower self-efficacy of self-care, and less adherence with
medication and diet self-care recommendations. Low literacy/numeracy is also associated with
higher blood pressures, more proteinuria, and more severe dysfunction of renal clearance.
Specific Aim 2: Evaluate the impact of a tailored literacy-sensitive educational tool used
cooperatively by physicians and patients to improve self-care and outcomes in CKD.
Hypothesis: Utilization of a concise literacy-sensitive physician-delivered educational tool
will be feasible and associated with higher patient kidney knowledge, self-efficacy of
self-care and greater adherence to medication and nutrition recommendations compared to
usual care.
Status | Completed |
Enrollment | 273 |
Est. completion date | June 2013 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Receiving care in the Vanderbilt General Nephrology Clinic for at least 1 prior visit past 12 months; - Serum creatinine available in the medical record in the last 12 months demonstrating Chronic Kidney Disease (eGFR<60mls/min); - Age 18-80 years; - English-speaking. Exclusion Criteria: - Pre-existing diagnosis of significant dementia or psychosis as determined by primary provider and documented in the medical record; - Corrected visual Acuity >60/20 using a Rosenbaum Pocket Vision Screen; - Patient receives dialysis or has a functional kidney transplant. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Vanderbilt University Medical Center | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | self-care of Chronic Kidney Disease | Change from baseline in the following surveys/questionaires at 6 months Morisky 8-Item Survey Frequent Food Questionaire |
baseline and 6 months | No |
Secondary | patient understanding of kidney disease and their disease status | Change from baseline in the following surveys/questionaires at 6 months Kidney Awareness & Knowledge Survey Perceived Kidney Self-Management Scale Kidney Disease Self-Management Behaviors |
baseline and 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |